When do we need to hospitalize a patient with community-acquired pneumonia?;Quando ospedalizzare un paziente con polmonite acquisita in comunità

Rassegna di Patologia dell'Apparato Respiratorio

Volumn 28, Issue 4, 2013, Pages 189-195

  Bonaiti, Giulia ^a   Aliberti, Stefano ^a   Suigo, Giulia ^a   Belloni, Francesca ^a   Giuliani, Fabio ^b   Pesci, Alberto ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

CAP; Community acquired pneumonia; CURB; Hospitalization; PSI; Severity score

Indexed keywords

COMMUNITY ACQUIRED PNEUMONIA; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; REVIEW;

EID: 84885208029     PISSN: 00339563     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Giusti M, Banfi F, Perrone F, et al. Community-acquired pneumonia: a budget impact model. Infez Med 2010;18:143-53.
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72.
3. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011;17(Suppl 6):E1-59.
4. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1-55.
5. Chalmers JD, Taylor J, Mandal P, et al. Validation of the IDSA/ATS minor criteria for ICU admission in community-acquired pneumonia patients without major criteria or contraindications to ICU care. Clin Infect Dis 2011;53:107-13.
6. Rello J, Rodriguez A, Lisboa T, et al. PIRO score for communityacquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with communityacquired pneumonia. Crit Care Med 2009;37:456-62.
7. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008;47:375-84. Rassegna di Patologia dell'Apparato Respiratorio
8. Kohno S, Seki M, Watanabe A. Evaluation of an assessment system for the JRS 2005: A-DROP for the management of CAP in adults. Intern Med 2011;50:1183-91.
9. Buising KL, Thursky KA, Black JF, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007;19:418-26.
10. Renaud B, Labarere J, Coma E, et al. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 2009;13:R54.
11. Yandiola PP, Capelastegui A, Quintana J, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with communityacquired pneumonia. Chest 2009;135:1572-9.
12. Chalmers JD, Mandal P, Singanayagam A, et al. Severity assessment tools to guide ICU admission in communityacquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011;37:1409-20.
13. Dean NC, Jones JP, Aronsky D, et al. Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department. Ann Emerg Med 2012;59:35-41.
14. Fine MJ, Hough LJ, Medsger AR, et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997;157:36-44.
15. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
16. Woodhead M. Assessment of illness severity in community acquired pneumonia: a useful new prediction tool? Thorax 2003;58:371-2.
17. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
18. Capelastegui A, España PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006, 27:151-7.
19. Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010;65:878-83.
20. Chen JH, Chang SS, Liu JJ, et al. Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax 2010;65:971-7.
21. Heppner HJ, Sehlhoff B, Niklaus D, et al. Pneumonia Severity Index (PSI), CURB-65, and mortality in hospitalized elderly patients with aspiration pneumonia. Z Gerontol Geriatr 2011;44:229-34.
22. Fang WF, Yang KY, Wu Cl, et al. Application and comparison of severity indices to predict outcomes in patients with healthcare-associated pneumonia. Crit Care 2011;15:R32.
23. Pereira JM, Moreno RP, Matos R, et al. Severity assessment tools in ICU patients with 2009 Influenza A (H1N1) pneumonia. Clin Microbiol Infect 2012;18:1040-8.
24. Aliberti S, Brock GN, Peyrani P, et al. The pneumonia severity index and the CRB-65 in cancer patients with communityacquired pneumonia. Int J Tuberc Lung Dis 2009;13:1550-6.
25. Asai N, Motojima S, Ohkuni Y, et al. Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity? Multidiscip Respir Med 2012;7:2.
26. Nathwani D, Morgan M, Masterton RG, et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008;61:976-94.
27. Menéndez R, Martínez R, Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in communityacquired pneumonia. Thorax 2009;64:587-91.
28. Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349-55.
29. Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008;52:48-58.
30. Krüger S, Ewig S, Giersdorf S, et al. Cardiovascular and inflammatory biomarkers to predict short-and longterm survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010;182:1426-34.
31. Courtais C, Kuster N, Dupuy AM, et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Am J Emerg Med 2012; Sep. 20. pii: S0735-6757 (12) 00376-2. doi: 10.1016/j.ajem.2012.07.017.
32. Albrich WC, Dusemund F, Rüegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011;11:112.
33. Krüger S, Papassotiriou J, Marre R, et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 2007;33:2069-78.
34. Christ-Crain M, Stolz D, Jutla S, et al. Free and total cortisol levels as predictors of severity and outcome in communityacquired pneumonia. Am J Respir Crit Care Med 2007;176:913-20.
35. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000;283:749-55.
36. Renaud B, Coma E, Labarere J, et al Routine use of the pneumonia severity index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 2007;44:41-9.
37. Chalmers JD, Akram AR, Hill AT. Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis. Eur Respir J 2011;37:858-64.
38. Seymann G, Barger K, Choo S, et al. Clinical judgment versus the Pneumonia Severity Index in making the admission decision. J Emerg Med 2008;34:261-8.
39. Arnold FW, Ramirez JA, McDonald LC, et al. Hospitalization for communityacquired pneumonia: the pneumonia severity index vs clinical judgement. Chest 2003;124:121-4.
40. Ewig S, de Roux A, Garcia E, et al. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 2004;59:421-7.
41. Aujesky D, McCausland JB, Whittle J, et al. Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. Clin Infect Dis 2009;49:e100-8.
42. Singanayagam A, Wood V, Chalmers JD. Factors associated with severe illness in Pandemic 2009 influenza A (H1N1) infection: implications for triage in primary and secondary care. J Infect 2011;63:243-51.
43. Aliberti S, Ramirez J, Cosentini R, et al. Low CURB-65 is of limited value in deciding discharge of patients with communityacquired pneumonia. Respir Med 2011;105:1732-8.
44. Choudhury G, Chalmers JD, Mandal P, et al. Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients. Eur Respir J 2011;38:643-8.
45. Kolditz M, Ewig S, Höffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. Eur Respir J 2013;41:974-84.
46. Serisier D, Williams S, Bowler S. Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia. Respirology 2012, doi: 10.1111/j.1440-1843.2012.02275.x.
47. Akram AR, Chalmers JD, Hill AT. Predicting mortality with severity assessment tools in out-patients with communityacquired pneumonia. QJM 2011;104:871-879.
48. McNally M, Curtain J, O'Brien KK, et al. Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis. Br J Gen Pract 2010;60:e423-433.